Evidence map›Paper›PMID 24261687›Full record

Trial reportBMC bioinformatics2013

MetSizeR: selecting the optimal sample size for metabolomic studies using an analysis based approach.

Gift Nyamundanda, Isobel Claire Gormley, Yue Fan, William M Gallagher, Lorraine Brennan

2 registry-linked trialsAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC bioinformatics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 79 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02342340 nacompletednot on this mapstarted 2015, after this paper: background citation

A Blinded, Randomized, Controlled Study to Examine the Bioavailability of Compounds From Different Bean Varieties in Healthy Individuals.

TypeinterventionalSponsorDr. Peter ZahradkaRan2015 to 2016Enrolled8ConditionsHealthyArmsNavy Beans (cooked), Red Kidney Beans (cooked), Pinto Beans (cooked, Black Beans (cooked), Lentils (cooked)
NCT06900270 recruitingnot on this mapstarted 2024, after this paper: background citation

Cross-sectional Cohort Analysis of Plasma Proteomics in Coronary Artery Disease and Plasma Metabolomics in Coronary Artery Disease: Comparative Study Between Patients with Obstructive (≥ 50%), Non-obstructive (< 50%) and No Lesions

TypeobservationalSponsorUniversity of Sao Paulo General HospitalRan2024 to 2026Enrolled66ConditionsCoronary Arterial Disease (CAD)
3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Article
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Artificial intelligence to investigate metabolomics data for precision medicine.Metabolomics : Official journal of the Metabolomic Society · 2026
    Review
  18. Article
  19. Article
  20. Article

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Gift NyamundandaSchool of Mathematical Sciences, University College Dublin, Dublin, Ireland. claire.gormley@ucd.ie.
Isobel Claire Gormley
Yue Fan
William M Gallagher
Lorraine Brennan

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDetermining sample sizes for metabolomic experiments is important but due to the complexity of these experiments, there are currently no standard methods for sample size estimation in metabolomics. Since pilot studies are rarely done in metabolomics, currently existing sample size estimation approaches which rely on pilot data can not be applied.

resultsIn this article, an analysis based approach called MetSizeR is developed to estimate sample size for metabolomic experiments even when experimental pilot data are not available. The key motivation for MetSizeR is that it considers the type of analysis the researcher intends to use for data analysis when estimating sample size. MetSizeR uses information about the data analysis technique and prior expert knowledge of the metabolomic experiment to simulate pilot data from a statistical model. Permutation based techniques are then applied to the simulated pilot data to estimate the required sample size.

conclusionsThe MetSizeR methodology, and a publicly available software package which implements the approach, are illustrated through real metabolomic applications. Sample size estimates, informed by the intended statistical analysis technique, and the associated uncertainty are provided.

Indexed as

AlgorithmsAnimalsComputer SimulationLongitudinal StudiesMetabolomicsModels, StatisticalNuclear Magnetic Resonance, BiomolecularPilot ProjectsPrincipal Component AnalysisSample SizeSoftware

Identifiers

PMID24261687
PMCPMC4222287

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.